Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 15 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. IL 259901

    Functionalized macrocycle chelators, complexes containing same and uses thereof as contrast agents

    BRACCO IMAGING SPA [IT] · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  2. US 10028999

    PAR-1 based therapeutic conjugates and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  3. US 10022325

    Compositions and methods for the treatment of cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  4. US 10023652

    Method of targeting glycoproteins to treat cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  5. US 10022375

    Methods and compositions for inhibition of polymerase

    BioCryst Pharmaceuticals, Inc. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  6. US 10022364

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  7. US 10022382

    RNA polymerase I inhibitors and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  8. US 9993449

    (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma

    Northwestern University · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

  9. US 9987326

    Klotho protein and related compounds for the treatment and diagnosis of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted

  10. US 9982236

    Cell populations, methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 29, 2018 · Expires May 24, 2038

    granted

  11. US 9974866

    Protein-poly(2-oxazoline) conjugates for enhanced cellular delivery and transport across biological barriers

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 22, 2018 · Expires May 17, 2038

    granted

  12. US 9974868

    Octapod iron oxide nanoparticles as high performance T2 contrast agents for magnetic resonance imaging

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 22, 2018 · Expires May 17, 2038

    granted

  13. US 9975944

    Synthetic peptides for the treatment of autoimmune diseases

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 22, 2018 · Expires May 17, 2038

    granted

  14. US 9962352

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 8, 2018 · Expires May 3, 2038

    granted

  15. US 9962385

    Methods and compositions for treating abnormal cell growth

    VERASTEM, INC. · Granted May 8, 2018 · Expires May 3, 2038

    granted

  16. US 9956215

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

  17. CA 3034568

    PROCEDE DE PREVENTION D'ATTAQUES AIGUES D'OEDEME DE QUINCKE HEREDITAIRE ASSOCIEES A UNE DEFICIENCE EN INHIBITEUR DE C1 ESTERASE

    CSL BEHRING GMBH [DE] · Granted Mar 1, 2018 · Expires Feb 24, 2038

    granted

  18. US 9903855

    Assays for screening for or identifying an agent or molecule that can block or inhibit AVB3 integrin from forming a complex with KRAS

    The Regents of the University of California · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted

  19. US 9901619

    Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes

    The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted

  20. US 9895411

    Analogs of C5a and methods of using same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  21. US 2018036436

    ETHYLENEDIAMINETETRAACETIC ACID BIS(AMIDE) DERIVATIVES AND THEIR RESPECTIVE COMPLEXES WITH MN(II) ION FOR USE AS MRI CONTRAST AGENT

    BRACCO IMAGING SPA [IT] · Granted Feb 8, 2018 · Expires Feb 3, 2038

    granted

  22. US 9867846

    Atopic-dermatitis-suppressing fiber, fiber assembly and fiber product, method for using same, and method for suppressing atopic dermatitis

    Kurashiki Boseki Kabushiki Kaisha · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  23. US 9856231

    Tetrahydrothiophene-based GABA aminotransferase inactivators

    Northwestern University · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  24. US 9850313

    Cancer biomarkers and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.